Amphastar Pharmaceuticals Inc AMPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
-
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
-
Amphastar Pharmaceuticals Shares Down 9% After Private Notes Offering
Trading Information
- Previous Close Price
- $46.32
- Day Range
- $46.39–47.39
- 52-Week Range
- $36.56–65.92
- Bid/Ask
- $46.42 / $49.88
- Market Cap
- $2.29 Bil
- Volume/Avg
- 167,665 / 374,631
Key Statistics
- Price/Earnings (Normalized)
- 11.65
- Price/Sales
- 3.47
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 2.56%
Company Profile
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,761
- Website
- https://www.amphastar.com
Comparables
Valuation
|
Metric
|
AMPH
|
NIKA
|
NDOI
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.65 | — | — |
Price/Book Value | 3.21 | — | — |
Price/Sales | 3.47 | — | — |
Price/Cash Flow | 10.16 | — | — |
Price/Earnings
AMPH
NIKA
NDOI
Financial Strength
|
Metric
|
AMPH
|
NIKA
|
NDOI
|
|---|---|---|---|
Quick Ratio | 2.55 | 0.33 | — |
Current Ratio | 3.52 | 0.35 | — |
Interest Coverage | 5.80 | — | — |
Quick Ratio
AMPH
NIKA
NDOI
Profitability
|
Metric
|
AMPH
|
NIKA
|
NDOI
|
|---|---|---|---|
Return on Assets (Normalized) | 14.18% | −113.73% | — |
Return on Equity (Normalized) | 33.14% | — | — |
Return on Invested Capital (Normalized) | 18.97% | — | — |
Return on Assets
AMPH
NIKA
NDOI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Pydjxcvvzg | Fqmj | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Jdjmkcjjmz | Rzdypx | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Zyzyfmvw | Cwjdd | $45.9 Bil | |||
| Viatris Inc
VTRS
| Rnhxcyh | Gytf | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Lrtyprt | Zmh | $13.2 Bil | |||
| Catalent Inc
CTLT
| Rjltcndv | Jtqrd | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Mmgrbbnwm | Kgpgxcr | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Vlzlwgpq | Zdps | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rpqjstyrb | Wwmh | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ttjbgkl | Hddx | $2.2 Bil |
United States